Sign In

Login

Password

Forgot Password ? Sign Up

アリスキレン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "アリスキレン" in Japanese language version.

refsWebsite
Global rank Japanese rank
5doi.org
2nd place
6th place
4nih.gov
4th place
24th place
2nejm.org
2,374th place
2,486th place
1prescrire.org
low place
low place
1healthzone.ca
low place
low place
1wikipedia.org
low place
low place
1elsevier.com
610th place
915th place
1sciencedirect.com
149th place
558th place
1adisonline.com
low place
low place
1drugs.com
399th place
1,603rd place
1pharmaxchange.info
low place
low place

adisonline.com

doi.org

  • Parving, Hans-Henrik; Barry M. Brenner, M.D., Ph.D., John J.V. McMurray, M.D., Dick de Zeeuw, M.D., Ph.D., Steven M. Haffner, M.D., Scott D. Solomon, M.D., Nish Chaturvedi, M.D., Frederik Persson, M.D., Akshay S. Desai, M.D., M.P.H., Maria Nicolaides, M.D., Alexia Richard, M.Sc., Zhihua Xiang, Ph.D., Patrick Brunel, M.D., and Marc A. Pfeffer, M.D., Ph.D. for the ALTITUDE Investigators (2012). “Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes”. NEJM 367 (23): 2204–13. doi:10.1056/NEJMoa1208799. PMID 23121378. http://www.nejm.org/doi/full/10.1056/NEJMoa1208799. 
  • Gradman A, Schmieder R, Lins R, Nussberger J, Chiang Y, Bedigian M (2005). “Aliskiren, a novel orally effective renin inhibitor（英語版）, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients”. Circulation 111 (8): 1012–8. doi:10.1161/01.CIR.0000156466.02908.ED. PMID 15723979. 
  • Straessen JA, Li Y, and Richart T (2006). “Oral Renin Inhibitors”. Lancet 368 (9545): 1449–56. doi:10.1016/S0140-6736(06)69442-7. PMID 17055947. http://linkinghub.elsevier.com/retrieve/pii/S0140673606694427. 
  • Baldwin CM, Plosker GL.[1]. doi:10.2165/00003495-200969070-00004. Drugs 2009; 69(7):833-841.
  • Ingelfinger JR (June 2008). “Aliskiren and dual therapy in type 2 diabetes mellitus”. N. Engl. J. Med. 358 (23): 2503–5. doi:10.1056/NEJMe0803375. PMID 18525047. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18525047&promo=ONFLNS19. 

drugs.com

elsevier.com

linkinghub.elsevier.com

healthzone.ca

nejm.org

nejm.org

  • Parving, Hans-Henrik; Barry M. Brenner, M.D., Ph.D., John J.V. McMurray, M.D., Dick de Zeeuw, M.D., Ph.D., Steven M. Haffner, M.D., Scott D. Solomon, M.D., Nish Chaturvedi, M.D., Frederik Persson, M.D., Akshay S. Desai, M.D., M.P.H., Maria Nicolaides, M.D., Alexia Richard, M.Sc., Zhihua Xiang, Ph.D., Patrick Brunel, M.D., and Marc A. Pfeffer, M.D., Ph.D. for the ALTITUDE Investigators (2012). “Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes”. NEJM 367 (23): 2204–13. doi:10.1056/NEJMoa1208799. PMID 23121378. http://www.nejm.org/doi/full/10.1056/NEJMoa1208799. 

content.nejm.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Parving, Hans-Henrik; Barry M. Brenner, M.D., Ph.D., John J.V. McMurray, M.D., Dick de Zeeuw, M.D., Ph.D., Steven M. Haffner, M.D., Scott D. Solomon, M.D., Nish Chaturvedi, M.D., Frederik Persson, M.D., Akshay S. Desai, M.D., M.P.H., Maria Nicolaides, M.D., Alexia Richard, M.Sc., Zhihua Xiang, Ph.D., Patrick Brunel, M.D., and Marc A. Pfeffer, M.D., Ph.D. for the ALTITUDE Investigators (2012). “Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes”. NEJM 367 (23): 2204–13. doi:10.1056/NEJMoa1208799. PMID 23121378. http://www.nejm.org/doi/full/10.1056/NEJMoa1208799. 
  • Gradman A, Schmieder R, Lins R, Nussberger J, Chiang Y, Bedigian M (2005). “Aliskiren, a novel orally effective renin inhibitor（英語版）, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients”. Circulation 111 (8): 1012–8. doi:10.1161/01.CIR.0000156466.02908.ED. PMID 15723979. 
  • Straessen JA, Li Y, and Richart T (2006). “Oral Renin Inhibitors”. Lancet 368 (9545): 1449–56. doi:10.1016/S0140-6736(06)69442-7. PMID 17055947. http://linkinghub.elsevier.com/retrieve/pii/S0140673606694427. 
  • Ingelfinger JR (June 2008). “Aliskiren and dual therapy in type 2 diabetes mellitus”. N. Engl. J. Med. 358 (23): 2503–5. doi:10.1056/NEJMe0803375. PMID 18525047. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18525047&promo=ONFLNS19. 

pharmaxchange.info

prescrire.org

english.prescrire.org

sciencedirect.com

wikipedia.org

en.wikipedia.org